NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
18/11/2025
Voltar para busca
Dado oficial do USPTO
ALPHATAC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
02/12/2022
Data de registro
18/11/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/11/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Gent, BE
Examinador
CORWIN, KEVIN SCOTT
Unidade examinadora
M30
Localização atual
INTENT TO USE SECTION
Titulares e representantes
Titulares
V. V. (pessoa física)
Representantes
Clifford D. Hyra FRESH IP PLC
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations and substancesbiotherapeutics for targeted protein degradation in cancerimmunological diseaseautoimmunological disease; Medical preparations and substancesliquidsolidlyophilized protein-based preparations for medical uses and treatments for cancerimmunological diseaseautoimmunological disease; Medical and veterinary preparations and substances in the nature of liquidsolidlyophilized protein-based biotherapeutic preparations for the treatmentmitigationdiagnosisprevention of diseasesconditionssymptoms related to metabolismallergiesimmune and inflammatory diseasesinfectious diseasesthe cardiovascular systemthe pulmonary systemthe respiratory systemoncologydermatologythe gastrointestinal systemtopical illnessesneurologyendocrinologythe urological systemthe reproductive systemnutritional needsophthalmic systemrenal systemblood and blood-related disordersintegumentary and lymphatic systems in humans and animals; Veterinary preparations in the nature of medication for use in the treatmentmitigationdiagnosisprevention of diseasesconditionssymptoms related to metabolismallergiesimmune and inflammatory diseasesinfectious diseasesthe cardiovascular systemthe pulmonary systemthe respiratory systemoncologydermatologythe gastrointestinal systemtopical illnessesneurologyendocrinologythe urological systemthe reproductive systemnutritional needsophthalmic systemrenal systemblood and blood-related disordersintegumentary and lymphatic systems in humans and animals; therapeutic preparations for pharmaceuticalmedical and veterinary purposespharmaceutical preparations for the treatment of diseasecancerimmunological disordersautoimmunological disorders in humans and animals; bioculture preparations for pharmaceuticalmedicalveterinary purposescultures of microorganisms for medical or veterinary use; Preparations and substances for use in drug discoveryclinical medical reagents; all of the aforesaid goods excluding means for pest controlfungicidesgermicides and herbicides and excluding means for diagnostics
Classe 42
Science and technology servicesscientific and technological research in the field of pharmaceuticalsmedical scienceveterinary science; Natural science servicesscientific research; Scientific researchmedicalbacteriologicalchemicalbio-technical and pharmacological research services; Clinical researchscientific research in the nature of conducting clinical trials for others; medical laboratory services; conducting early evaluations in the field of new pharmaceuticals; Consultancy relating to pharmaceutical research and development; Drug discovery services; all of the aforesaid services not relating to means for pest controlfungicidesgermicides and herbicidenot relating to means for diagnostics
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
18/11/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
29/10/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
29/10/2025
CORV
REVIEW OF CORRESPONDENCE COMPLETE
29/10/2025
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
24/09/2025
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
22/05/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/05/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/03/2025
PUBO
PUBLISHED FOR OPPOSITION
11/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/03/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
19/12/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/12/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
30/08/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
30/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/08/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/08/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
30/08/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
31/05/2024
GNFR
FINAL REFUSAL E-MAILED
31/05/2024
CNFR
FINAL REFUSAL WRITTEN
31/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/12/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/09/2023
GNRT
NON-FINAL ACTION E-MAILED
23/09/2023
CNRT
NON-FINAL ACTION WRITTEN
23/09/2023
DOCK
ASSIGNED TO EXAMINER
12/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/12/2022
NWAP
NEW APPLICATION ENTERED
06/12/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ALPHATAC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.